Safety of dapagliflozin initiation in acute decompensated heart failure patients with reduced left ventricular ejection fraction
Background. Chronic heart failure (CHF) is an immediate cardiological problem. At the same time, acute decompensated heart failure (ADHF) is associated with an extremely unfavorable prognosis and low survival of patients. Aim. To evaluate the safety of sodium-glucose cotransporter-2 inhibitor dapagl...
Saved in:
Main Authors: | Anastasiya E. Poskakalova (Author), Svetlana N. Nasonova (Author), Igor V. Zhirov (Author), Sergey N. Tereshchenko (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SGLT-2 inhibitors in the management of acute decompensated heart failure
by: Anastasia E. Poskakalova, et al.
Published: (2024) -
Hyperuricemia and acute decompensation of heart failure: is there a causative link? A review
by: Laura H. Sarieva, et al.
Published: (2024) -
Pediatric heart failure classification based on left ventricular ejection fraction
by: Shan Huang, et al.
Published: (2023) -
Chronic heart failure - modification of treatment paradigm
by: Svetlana N. Nasonova, et al.
Published: (2022) -
DIASTOLIC LEFT VENTRICULAR DYSFUNCTION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION IN ELDERLY
by: CALENICI Oleg, et al.
Published: (2022)